PSYCHLES
@psychles.bsky.social
Researching legal, ethical, and social aspects of Psychedelics at the University of Birmingham. Current project: 'Psychedelics & Regulatory Decision-making'.
Pinned
PSYCHLES
@psychles.bsky.social
· May 29
👋Hi everyone! We are an interdisciplinary group of researchers from @unibirmingham.bsky.social working on the the legal, ethical, social, and other challenges relating to the therapeutic use of psychedelics (e.g. psilocybin & MDMA). #Psychedelics #PsychedelicResearch #MedicinesRegulation
Great day with rich discussions. The talks all went so well together. #psychedelics #phenomenology #mentalhealth @uobphenomenal.bsky.social
November 5, 2025 at 3:42 PM
Great day with rich discussions. The talks all went so well together. #psychedelics #phenomenology #mentalhealth @uobphenomenal.bsky.social
And we're off to the races. Great lineup for today's @uobphenomenal.bsky.social seminar. Joined by speakers from Imperial, Exeter, Amsterdam, & Birmingham. #psychedelics #interdisciplinary #phenomenology #mentalhealth
November 5, 2025 at 11:47 AM
And we're off to the races. Great lineup for today's @uobphenomenal.bsky.social seminar. Joined by speakers from Imperial, Exeter, Amsterdam, & Birmingham. #psychedelics #interdisciplinary #phenomenology #mentalhealth
Looking forward to the talks at our Psychedelics, Phenomenology, & Mental Health workshop as part of the Birmingham Network for Phenomenology & Mental Health. Sign up & schedule in the link.
Our schedule for our next network seminar has now been finalised!
Check out our website for the full list of awesome talks:
birminghamphenomenalnetwork.blogspot.com/2025/10/netw...
P.S. there's still time to register!
Check out our website for the full list of awesome talks:
birminghamphenomenalnetwork.blogspot.com/2025/10/netw...
P.S. there's still time to register!
October 24, 2025 at 3:24 PM
Looking forward to the talks at our Psychedelics, Phenomenology, & Mental Health workshop as part of the Birmingham Network for Phenomenology & Mental Health. Sign up & schedule in the link.
🌿 Facing the end of life can bring immense distress. Could psychedelic therapy help ease the journey?
drugscience.org.uk/easing-end-of-life-distress-psychedelic-uk
@profjoneill.bsky.social, Laura Downey, & @profmq.bsky.social for @drugscience.bsky.social
#PalliativeCare #Psychedelics #DrugScience
drugscience.org.uk/easing-end-of-life-distress-psychedelic-uk
@profjoneill.bsky.social, Laura Downey, & @profmq.bsky.social for @drugscience.bsky.social
#PalliativeCare #Psychedelics #DrugScience
Easing End-of-Life Distress: Should Psychedelic Therapy Be Part of Palliative Care in the UK?
Facing a terminal diagnosis is one of life’s most difficult challenges. Beyond the physical burden of illness, patients often experience anxiety, depression, insomnia, and existential distress – a sen...
drugscience.org.uk
September 18, 2025 at 9:26 AM
🌿 Facing the end of life can bring immense distress. Could psychedelic therapy help ease the journey?
drugscience.org.uk/easing-end-of-life-distress-psychedelic-uk
@profjoneill.bsky.social, Laura Downey, & @profmq.bsky.social for @drugscience.bsky.social
#PalliativeCare #Psychedelics #DrugScience
drugscience.org.uk/easing-end-of-life-distress-psychedelic-uk
@profjoneill.bsky.social, Laura Downey, & @profmq.bsky.social for @drugscience.bsky.social
#PalliativeCare #Psychedelics #DrugScience
Reposted by PSYCHLES
The Dutch Medicines Evaluation Board will host a Pipeline Meeting on 5 Nov 2025, focusing on the regulatory development of psychedelics.
Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators.
Deadline: 29 Aug tinyurl.com/meb-pipeline...
Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators.
Deadline: 29 Aug tinyurl.com/meb-pipeline...
August 28, 2025 at 1:05 PM
The Dutch Medicines Evaluation Board will host a Pipeline Meeting on 5 Nov 2025, focusing on the regulatory development of psychedelics.
Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators.
Deadline: 29 Aug tinyurl.com/meb-pipeline...
Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators.
Deadline: 29 Aug tinyurl.com/meb-pipeline...
Reposted by PSYCHLES
Pα+ Psychedelic Bulletin #207
- Lykos Rebrands to Resilient
- Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision
- AbbVie-Gilgamesh Deal Viewed as Validation
- Psilocybin Rescheduling Petition Heads to HHS
- Much, much more...
psychedelicalpha.com/news/p%ce%b1...
- Lykos Rebrands to Resilient
- Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision
- AbbVie-Gilgamesh Deal Viewed as Validation
- Psilocybin Rescheduling Petition Heads to HHS
- Much, much more...
psychedelicalpha.com/news/p%ce%b1...
Pα+ Psychedelic Bulletin #207: Lykos Rebrands to Resilient; Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision; AbbVie-Gilgamesh Deal Viewed as Validation - Psychedelic Alpha
Lykos Therapeutics Rebrands to Resilient Pharmaceuticals • Pharma Pushes Back on Norway’s Off-Label Ketamine Decision • AbbVie–Gilgamesh Deal Viewed as Validation for Short-Acting Psychedelics •
psychedelicalpha.com
August 28, 2025 at 5:08 PM
Pα+ Psychedelic Bulletin #207
- Lykos Rebrands to Resilient
- Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision
- AbbVie-Gilgamesh Deal Viewed as Validation
- Psilocybin Rescheduling Petition Heads to HHS
- Much, much more...
psychedelicalpha.com/news/p%ce%b1...
- Lykos Rebrands to Resilient
- Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision
- AbbVie-Gilgamesh Deal Viewed as Validation
- Psilocybin Rescheduling Petition Heads to HHS
- Much, much more...
psychedelicalpha.com/news/p%ce%b1...
Reposted by PSYCHLES
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵
www.medrxiv.org/content/10.1...
www.medrxiv.org/content/10.1...
August 18, 2025 at 1:17 PM
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵
www.medrxiv.org/content/10.1...
www.medrxiv.org/content/10.1...
Delighted to be part of this great new network at Birmingham, and quietly working on putting together a psychedelics and lived experience workshop as part of its activities!
👋Hi everyone!
We're the Birmingham Network for Phenomenology and Mental Health - an interdisciplinary network of researchers from @unibirmingham.bsky.social working on phenomenology and mental health
We're the Birmingham Network for Phenomenology and Mental Health - an interdisciplinary network of researchers from @unibirmingham.bsky.social working on phenomenology and mental health
August 19, 2025 at 12:41 PM
Delighted to be part of this great new network at Birmingham, and quietly working on putting together a psychedelics and lived experience workshop as part of its activities!
Reposted by PSYCHLES
Reframing Psychedelic Regulation: Tools, not Treatments
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
June 16, 2025 at 12:03 PM
Reframing Psychedelic Regulation: Tools, not Treatments
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
Reposted by PSYCHLES
Come and study an MSc in 'Psychǝdǝlics: Mind, Medicine, and Culture' at Exeter – now on-campus too. Here's a lovely new video of one of our students, Nina, speaking on her experience:
June 13, 2025 at 8:39 AM
Come and study an MSc in 'Psychǝdǝlics: Mind, Medicine, and Culture' at Exeter – now on-campus too. Here's a lovely new video of one of our students, Nina, speaking on her experience:
Reposted by PSYCHLES
Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year after dosing themicrodose.substack.com/p/texas-pass...
Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year after dosing
Plus: Oregon Psilocybin services releases its first quarterly demographic data report and Could the Czech Republic be the first EU country to approve psilocybin-assisted therapy?
themicrodose.substack.com
June 13, 2025 at 5:29 PM
Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year after dosing themicrodose.substack.com/p/texas-pass...
Reposted by PSYCHLES
European Drug Report 2025: Trends and Developments now published. EUDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply and key harm reduction interventions. - www.euda.europa.eu/publications...
June 5, 2025 at 11:28 AM
European Drug Report 2025: Trends and Developments now published. EUDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply and key harm reduction interventions. - www.euda.europa.eu/publications...
👋Hi everyone! We are an interdisciplinary group of researchers from @unibirmingham.bsky.social working on the the legal, ethical, social, and other challenges relating to the therapeutic use of psychedelics (e.g. psilocybin & MDMA). #Psychedelics #PsychedelicResearch #MedicinesRegulation
May 29, 2025 at 12:44 PM
👋Hi everyone! We are an interdisciplinary group of researchers from @unibirmingham.bsky.social working on the the legal, ethical, social, and other challenges relating to the therapeutic use of psychedelics (e.g. psilocybin & MDMA). #Psychedelics #PsychedelicResearch #MedicinesRegulation
Reposted by PSYCHLES
Matt Zorn, the Government’s Former Adversary, Is Now Its Psychedelics Czar
Matt Zorn made his name suing federal agencies over cannabis and psychedelics policy. Now, he’s inside the system as Deputy General Counsel at HHS, with a psychedelics mandate.
psychedelicalpha.com/news/matt-zo...
Matt Zorn made his name suing federal agencies over cannabis and psychedelics policy. Now, he’s inside the system as Deputy General Counsel at HHS, with a psychedelics mandate.
psychedelicalpha.com/news/matt-zo...
Matt Zorn, the Government’s Former Adversary, Is Now Its Psychedelics Czar - Psychedelic Alpha
Matt Zorn made his name suing federal agencies over cannabis and psychedelics policy. Now, he’s inside the system as Deputy General Counsel at HHS, with what appears to be a mandate over psychedelics…
psychedelicalpha.com
May 24, 2025 at 5:32 PM
Matt Zorn, the Government’s Former Adversary, Is Now Its Psychedelics Czar
Matt Zorn made his name suing federal agencies over cannabis and psychedelics policy. Now, he’s inside the system as Deputy General Counsel at HHS, with a psychedelics mandate.
psychedelicalpha.com/news/matt-zo...
Matt Zorn made his name suing federal agencies over cannabis and psychedelics policy. Now, he’s inside the system as Deputy General Counsel at HHS, with a psychedelics mandate.
psychedelicalpha.com/news/matt-zo...
Reposted by PSYCHLES
New: We take a closer look at Gilgamesh's positive Phase 2a results of GM-2505 (aka bretisilocin, a serotonergic psychedelic) in major depressive disorder (MDD) & speak to company execs
The results should provide a welcome catalyst for the field.
psychedelicalpha.com/news/gilgame...
The results should provide a welcome catalyst for the field.
psychedelicalpha.com/news/gilgame...
Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive Disorder Study - Psychedelic Alpha
As Gilgamesh Pharmaceuticals is set to share positive results from its Phase 2a study of GM-2505 (aka bretisilocin, a serotonergic psychedelic) in major depressive disorder later today at ASCP…
psychedelicalpha.com
May 27, 2025 at 12:01 PM
New: We take a closer look at Gilgamesh's positive Phase 2a results of GM-2505 (aka bretisilocin, a serotonergic psychedelic) in major depressive disorder (MDD) & speak to company execs
The results should provide a welcome catalyst for the field.
psychedelicalpha.com/news/gilgame...
The results should provide a welcome catalyst for the field.
psychedelicalpha.com/news/gilgame...
Reposted by PSYCHLES
The WHO has issued a rapid communication on its forthcoming guideline on controlled medicines, on which PAREA participated as an external reviewer. tinyurl.com/who-gl-rc
May 27, 2025 at 12:56 PM
The WHO has issued a rapid communication on its forthcoming guideline on controlled medicines, on which PAREA participated as an external reviewer. tinyurl.com/who-gl-rc
Reposted by PSYCHLES
Interesting (critical) take on my recent New Yorker piece on psychedelics and religion. | Substack substack.com/home/post/p-...
Taking Psychedelic Spiritualities (More) Seriously
The release of a long-awaited study on psychedelics and religion ought to prompt new questions, not old cliches.
substack.com
May 27, 2025 at 9:53 PM
Interesting (critical) take on my recent New Yorker piece on psychedelics and religion. | Substack substack.com/home/post/p-...
Delighted to have welcomed participants to Birmingham last week for our roundtable on Psychedelics & Regulatory Decision-making. V interesting & fruitful discussion with a range of perspectives. #Psychedelics #PsychedelicExperience #PsychedelicResearch #PsychedelicMedicine #MedicinesRegulation
May 13, 2025 at 11:11 AM
Delighted to have welcomed participants to Birmingham last week for our roundtable on Psychedelics & Regulatory Decision-making. V interesting & fruitful discussion with a range of perspectives. #Psychedelics #PsychedelicExperience #PsychedelicResearch #PsychedelicMedicine #MedicinesRegulation
Reposted by PSYCHLES
Dispatch from Breaking Convention 2025: Part 2
Inside:
- Ethical dilemmas of giving psychedelics to young people
- Critical role of therapist selection,
- Female biology X psychedelics
- Pros/cons of non-hallucinogenic psychoplastogens
and more...
psychedelicalpha.com/news/dispatc...
Inside:
- Ethical dilemmas of giving psychedelics to young people
- Critical role of therapist selection,
- Female biology X psychedelics
- Pros/cons of non-hallucinogenic psychoplastogens
and more...
psychedelicalpha.com/news/dispatc...
Dispatch from Breaking Convention 2025: Key Takeaways from Europe’s Largest Psychedelic Summit (Part 2) - Psychedelic Alpha
From 17–19 April, the UK’s seventh biennial psychedelic conference tackled some of the field’s most urgent questions. In this second instalment, we explore the ethical dilemmas of giving psychedelics…
psychedelicalpha.com
May 12, 2025 at 4:51 PM
Dispatch from Breaking Convention 2025: Part 2
Inside:
- Ethical dilemmas of giving psychedelics to young people
- Critical role of therapist selection,
- Female biology X psychedelics
- Pros/cons of non-hallucinogenic psychoplastogens
and more...
psychedelicalpha.com/news/dispatc...
Inside:
- Ethical dilemmas of giving psychedelics to young people
- Critical role of therapist selection,
- Female biology X psychedelics
- Pros/cons of non-hallucinogenic psychoplastogens
and more...
psychedelicalpha.com/news/dispatc...
Reposted by PSYCHLES
Participate in the Global Psychedelic Survey 2025 (GPS 2025), a large global study on psychedelic use.
Sponsored by Uni of Michigan, closes May 16!
Win 1 of 15 $100 Amazon gift cards.
Take part: bit.ly/GPS2025-survey
#GPS2025 #PsychedelicResearch #GlobalSurvey
Sponsored by Uni of Michigan, closes May 16!
Win 1 of 15 $100 Amazon gift cards.
Take part: bit.ly/GPS2025-survey
#GPS2025 #PsychedelicResearch #GlobalSurvey
May 11, 2025 at 11:25 PM
Participate in the Global Psychedelic Survey 2025 (GPS 2025), a large global study on psychedelic use.
Sponsored by Uni of Michigan, closes May 16!
Win 1 of 15 $100 Amazon gift cards.
Take part: bit.ly/GPS2025-survey
#GPS2025 #PsychedelicResearch #GlobalSurvey
Sponsored by Uni of Michigan, closes May 16!
Win 1 of 15 $100 Amazon gift cards.
Take part: bit.ly/GPS2025-survey
#GPS2025 #PsychedelicResearch #GlobalSurvey